Scientific News

High sugar may promote severe fatty liver disease through gut bacteria

The findings suggest that L. salivarius can be a microbiota-based therapy for preventing severe fatty liver disease progression.

IBS Days: bridging science and clinical practice in irritable bowel syndrome

Giovanni Barbara (University of Bologna), Congress Chair, reflects on the key takeaways from the congress and shares his closing remarks.

Beyond antibiotic-associated diarrhea: probiotics, the gut microbiota, and the challenge of antimicrobial resistance

Francisco Guarner, from Centro Médico Teknon in Barcelona, discusses the role of probiotics in the prevention of antibiotic-associated diarrhea.

Microbiota differences might shape responses to viral infections

New study suggests that modifying the gut microbiota could shape baseline immune states to improve infection resistance and responses to vaccines and immunotherapies.

Dietary fiber helps probiotics settle in the gut

Diet shapes probiotic colonization, offering strategies to improve colonization, modulate the microbiota, and control harmful microbes.

Mapping the microbiome: ranking gut species linked to diet and cardiometabolic health

Francesco Asnicar, CIBIO - University of Trento (Italy), discusses new large-scale research on the human microbiome, based on the analysis of more than 35,000 individuals from the UK and the…

Mathematical model reveals how gut microbes shift in disease

Monitoring shifts in microbial interaction networks could help to detect and track gut-related conditions.

Gut microbiota maturation may be linked to infection risk in preterm babies

Bacteria such as Enterococcus faecium and Limosilactobacillus reuteri are key in activating an immune receptor that boosts the activity of protective immune cells.

High Resolution, Low Depth

The longevity industry is measuring everything except what matters most.

From stool reports to real-time decisions: making microbiome testing clinically actionable

Amine Zorgani explains how SwipeBiome moves beyond traditional stool testing toward real-time microbiome prediction based on patient metadata.

Success of microbiota transplants may depend on specific bacterial strains

Targeting specific bacterial strains, rather than overall gut diversity, can help develop effective microbiota therapies.

Single-cell analysis reveals how harmful bacteria may promote gum disease

In periodontitis, helpful gum bacteria become less active while harmful bacteria change their behavior to feed on available nutrients and worsen disease, suggesting new targeted treatment approaches.

How microbial metabolites shape allergy, asthma and obesity-related inflammation

Liam O’Mahony explores how diet influences the immune system through the metabolic activity of the gut microbiota.

Microbial particles may boost the effectiveness of immunotherapy in stomach cancer

Bacterial extracellular vesicles released by L. salivarius activate immune cells, boosting the effectiveness of immunotherapy in stomach cancer.

Hidden gut bacteria may be key to a healthy microbiota

Uncultured gut bacteria, particularly one group called CAG-170, are key contributors to a healthy microbiota. 

Dietary fiber and gastric cancer: pooled international data support a dose-dependent protective effect

Giulia Collattuzzo, University of Bologna, presents study findings showing an independent protective association between dietary fiber and gastric cancer risk, with consistent effects across sex, tumor location, and histological subtype.

The Fastest Lab on Earth

Why Formula 1 will build the future of personalised medicine before medicine does.

Region-specific infant gut bacteria may pave the way for tailored probiotics

Bifidobacterium longum and B. infantis are distinct species with strains adapted to local diets, highlighting the importance of developing geographically tailored infant probiotics.

Gut protein blocks harmful bacteria and protects intestinal health

HMGB1 is a key protein that blocks bacterial adhesion and virulence, protecting intestinal cells and helping to maintain a healthy microbiota.

IBS Days 2026: Bologna to host the European launch of the new Rome V criteria

The fifth edition of IBS Days, a congress entirely dedicated to Irritable Bowel Syndrome, will take place in Bologna, Italy, from June 15 to 17, 2026.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.